Journal of Infection
Volume 61, Issue 2 , Pages 133-143 , August 2010

IFN-γ, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis

  • Delia Goletti

      Affiliations

    • Translational Research Unit, Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Via Portuense 292, Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 55170 906 (954); fax: +39 06 5582 825.
    • ,
  • Alamelu Raja

      Affiliations

    • Department of Immunology, Tuberculosis Research Centre (ICMR), Tamil Nadu, India
    • ,
  • Basirudeen Syed Ahamed Kabeer

      Affiliations

    • Department of Immunology, Tuberculosis Research Centre (ICMR), Tamil Nadu, India
    • ,
  • Camilla Rodrigues

      Affiliations

    • Microbiology Department, P.D. Hinduja National Hospital and Research Center, Mumbai, India
    • ,
  • Archana Sodha

      Affiliations

    • Microbiology Department, P.D. Hinduja National Hospital and Research Center, Mumbai, India
    • ,
  • Ornella Butera

      Affiliations

    • Translational Research Unit, Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Via Portuense 292, Rome, Italy
    • ,
  • Stefania Carrara

      Affiliations

    • Translational Research Unit, Department of Epidemiology and Preclinical Research, L. Spallanzani National Institute for Infectious Diseases (INMI), Via Portuense 292, Rome, Italy
    • ,
  • Guy Vernet

      Affiliations

    • Scientific Direction, Fondation Mérieux, Lyon, France
    • ,
  • Christophe Longuet

      Affiliations

    • Scientific Direction, Fondation Mérieux, Lyon, France
    • ,
  • Giuseppe Ippolito

      Affiliations

    • Scientific Direction, INMI, Rome, Italy
    • ,
  • Satheesh Thangaraj

      Affiliations

    • BioMérieux, Research & Development Immunoasays, Chemin del’Orme, Marcy L’Etoile, France
    • ,
  • Marc Leportier

      Affiliations

    • BioMérieux, Research & Development Immunoasays, Chemin del’Orme, Marcy L’Etoile, France
    • ,
  • Enrico Girardi

      Affiliations

    • Department of Epidemiology and Preclinical Research, INMI, Rome, Italy
    • ,
  • Philippe Henri Lagrange

      Affiliations

    • Microbiology Service, Saint Louis Hospital, Paris, France

,Accepted 5 May 2010.

References 

  1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–184
  2. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001;357:2017–2021
  3. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004;170:59–64
  4. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168–1173
  5. Vincenti D, Carrara S, De Mori P, Pucillo LP, Petrosillo N, Palmieri F, et al. Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med. 2003;9:105–111
  6. Goletti D, Vincenti D, Carrara S, Butera O, Bizzoni F, Bernardini G, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol. 2005;12:1311–1316
  7. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004;38:754–756
  8. Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis. 2006;194:984–992
  9. Goletti D, Carrara S, Butera O, Amicosante M, Ernst M, Sauzullo I, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-study. PLoS ONE. 2008;3:e3417
  10. Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis. 2008;e28:11
  11. Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R, Dainotto D, et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res. 2007;8:5
  12. Ministero della Salute . http://www.ministerosalute.it/promozione/malattie/bollettino.jsp
  13. Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, van Meijgaarden KE, et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 2006;8:2052–2060
  14. Goletti D, Butera O, Vanini V, Lauria FN, Lange C, Franken KL, et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J. 2010;36:1–8
  15. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol. 2007;14:880–885
  16. Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis. 2007;7:99
  17. Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, Meraviglia S, et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis. 2009;9:182
  18. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol. 2007;178:5217–5226
  19. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, et al. Detection of IL-2 in addition to IFN-gamma discriminates active tuberculosis patients, latently infected individuals and controls. Clin Microbiol Infect, in press, doi:10.1111/j.1469-0691.2009.03104.x
  20. Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis. 2009;9:99
  21. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect. 2007;9:806–812
  22. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008;32:1607–1615
  23. Petrucci R, Abu Amer N, Gurgel RQ, Sherchand JB, Doria L, Lama C, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J. 2008;27:1073–1077
  24. Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, Lawson L, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One. 2008;6(3):e2858
  25. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PLoS One. 2008;3:e3901
  26. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123–128
  27. Korpi-Steiner NL, Bates ME, Lee WM, Hall DJ, Bertics PJ. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol. 2006;80:1364–1374
  28. Mezger M, Steffens M, Beyer M, Manger C, Eberle J, Toliat MR, et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood. 2008;111:534–536
  29. Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, et al. IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005;7:1–8
  30. Okamoto M, Kawabe T, Iwasaki Y, Hara T, Hashimoto N, Imaizumi K, et al. Evaluation of interferon-γ, interferon-γ-inducing cytokines, and interferon-γ-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med. 2005;145:88–93
  31. Berktas M, Guducuoglu H, Bozkurt H, Onbasi KT, Kurtoglu MG, Andic S. Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis. J Int Med Res. 2004;32:324–330
  32. Central TB Division, Directorate general of health services, ministry of health and family welfare . Revised National Tuberculosis Control Programme manual for laboratory technicians. New Delhi, India: Ministry of Health and Family Welfare; 2008;http://www.tbcindia.org/LABMANUAL.pdf
  33. Chadha VK, Jagannatha PS, Vaidyanathan PS, Jagota P. PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis. 2003;7:172–179
  34. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, Goswami K, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13:84–92

PII: S0163-4453(10)00133-7

doi: 10.1016/j.jinf.2010.05.002

Journal of Infection
Volume 61, Issue 2 , Pages 133-143 , August 2010

Article Tools

* Image Usage & Resolution